{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:05:10Z","timestamp":1793862310261,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019624","name":"University Hospital Hradec Kralove","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119091","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:11:10Z","timestamp":1782231070000},"page":"119091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7011-4102","authenticated-orcid":false,"given":"Priam-Amedeo","family":"Houngbedji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bacht\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila","family":"Boh\u00e1\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Tabarestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Jan\u010fourek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Kone\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"\u0150sterreicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Paterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"B\u00e1rta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Z\u00e1horszk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kordul\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Meneghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0104-9925","authenticated-orcid":false,"given":"Jan","family":"Zitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119091_bib1","series-title":"Global Tuberculosis Report 2025","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119091_bib2","series-title":"WHO Operational Handbook on Tuberculosis. Module 4: Treatment and Care","year":"2025"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119091_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1389557522666220819092431","article-title":"Anti-tubercular activity of pyrazinamide conjugates: synthesis and structure-activity relationship studies","volume":"23","author":"Simranpreet","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119091_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00070-19","article-title":"The bewildering antitubercular action of pyrazinamide","volume":"84","author":"Lamont","year":"2020","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119091_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/79558","article-title":"Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis","volume":"6","author":"Zimhony","year":"2000","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119091_bib6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschembio.1c00131","article-title":"Mycobacterium tuberculosis PanD structure\u2013function analysis and identification of a potent pyrazinoic acid-derived enzyme inhibitor","volume":"16","author":"Ragunathan","year":"2021","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119091_bib7","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.3390\/molecules15128567","article-title":"Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides","volume":"15","author":"Dolezal","year":"2010","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119091_bib8","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.bmcl.2013.04.021","article-title":"Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides","volume":"23","author":"Servusov\u00e1","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"12","key":"10.1016\/j.ejmech.2026.119091_bib9","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.3390\/molecules181214807","article-title":"Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-Chloro-N-phenylpyrazine-2-carboxamides","volume":"18","author":"Zitko","year":"2013","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119091_bib10","doi-asserted-by":"crossref","first-page":"13183","DOI":"10.3390\/molecules171113183","article-title":"Substituted N-Benzylpyrazine-2-carboxamides: synthesis and biological evaluation","volume":"17","author":"Servusov\u00e1","year":"2012","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.ejmech.2026.119091_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500085","article-title":"Investigating the mechanism of antimycobacterial and antiproliferative activity of (E)-N\u2019-Benzylidenepyrazine-2-Carbohydrazides and their derivatives","volume":"20","author":"Houngbedji","year":"2025","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119091_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1039\/C8MD00056E","article-title":"Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold","volume":"9","author":"Zitko","year":"2018","journal-title":"Medchemcomm"},{"issue":"16","key":"10.1016\/j.ejmech.2026.119091_bib13","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119091_bib14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1021\/ol070527h","article-title":"Efficient conversion of aromatic amines into azides: a one-pot synthesis of triazole linkages","volume":"9","author":"Barral","year":"2007","journal-title":"Org. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119091_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.tube.2008.06.001","article-title":"Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogs","volume":"88","author":"Chung","year":"2008","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119091_bib16","article-title":"A recent overview of 1,2,3-Triazole-Containing hybrids as novel antifungal agents: focusing on synthesis, mechanism of action, and structure-activity relationship (SAR)","volume":"2022","author":"Marzi","year":"2022","journal-title":"J. Chem."},{"key":"10.1016\/j.ejmech.2026.119091_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114888","article-title":"1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens","volume":"244","author":"Deng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119091_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126846","article-title":"The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles","volume":"30","author":"Reddyrajula","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119091_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119091_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijmyco.2015.05.001","article-title":"The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae","volume":"4","author":"Phelan","year":"2015","journal-title":"Int. J. Mycobacteriol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119091_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00337-22","article-title":"Mycobacterium smegmatis: the vanguard of mycobacterial research","volume":"205","author":"Sparks","year":"2023","journal-title":"J. Bacteriol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119091_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.imj.2025.100203","article-title":"The growing impact of nontuberculous mycobacteria: a multidisciplinary review of ecology, pathogenesis, diagnosis, and treatment","volume":"4","author":"Maleki","year":"2025","journal-title":"Infectious Medicine"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119091_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/ijmy.ijmy_33_18","article-title":"Mycobacterium tuberculosis strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs","volume":"7","author":"Heinrichs","year":"2018","journal-title":"Int. J. Mycobacteriol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119091_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/antibiotics11070873","article-title":"Mycobacterioses induced by Mycobacterium abscessus: case studies indicating the importance of molecular analysis for the identification of antibiotic resistance","volume":"11","author":"Ryskova","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119091_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.cmi.2023.09.019","article-title":"Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections","volume":"30","author":"Tunesi","year":"2024","journal-title":"Clin. Microbiol. Infection"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119091_bib26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0960327116660751","article-title":"Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics","volume":"36","author":"Elmorsy","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119091_bib27","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3390\/ijms24032914","article-title":"Optimization of the hemolysis assay for the assessment of cytotoxicity","volume":"24","author":"S\u00e6b\u00f8","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119091_bib28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s13104-017-2757-8","article-title":"Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials","volume":"10","author":"Ignasiak","year":"2017","journal-title":"BMC Res. Notes"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119091_bib29","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/JB.184.8.2167-2172.2002","article-title":"Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I","volume":"184","author":"Boshoff","year":"2002","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119091_bib30","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1128\/AAC.01458-06","article-title":"Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs","volume":"51","author":"Ngo","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119091_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2958.2002.03162.x","article-title":"Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis","volume":"46","author":"Larsen","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119091_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113668","article-title":"Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity","volume":"223","author":"Pfl\u00e9gr","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"46","key":"10.1016\/j.ejmech.2026.119091_bib33","doi-asserted-by":"crossref","first-page":"38434","DOI":"10.1074\/jbc.M112.400994","article-title":"A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone","volume":"287","author":"Grzegorzewicz","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119091_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70412","article-title":"Structural basis of product recognition by Mycobacterium tuberculosis fatty acid synthase","volume":"35","author":"Samani","year":"2026","journal-title":"Protein Sci."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119091_bib35","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.str.2013.04.023","article-title":"Structure and conformational variability of the Mycobacterium tuberculosis fatty acid synthase multienzyme complex","volume":"21","author":"Ciccarelli","year":"2013","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119091_bib36","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1038\/s41467-018-06440-6","article-title":"Structure of Type-I Mycobacterium tuberculosis fatty acid synthase at 3.3 \u00c5 resolution","volume":"9","author":"Elad","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119091_bib37","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/cbdv.201200291","article-title":"Analogs of the antituberculous agent pyrazinamide are competitive inhibitors of NADPH binding to M. tuberculosis fatty acid synthase I","volume":"9","author":"Sayahi","year":"2012","journal-title":"Chem. Biodivers."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:08:50Z","timestamp":1787040530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S0223523426005362"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119091","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrazinamide-derived 1,2,3-triazoles: Antimicrobial evaluation, selective antimycobacterial activity and mechanism of action insights","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119091"}}